MediKane Holdings Ltd provides natural plant-based products that now have proven health and medicinal benefits.
After seven years of building a business foundation, MediKane has two products on the market, one that assists in the control and reduction of Blood Sugar Levels, and one for post-operative hospital use. Extensive university work has resulted in extensive scientific and medical evidence that verify the product claims and importantly show how the products work within our bodies – The Modes of Action.
In addition, multiple clinical trials have demonstrated that MediKane products effectively treat specific chronic medical conditions.
The Blood Sugar management product – NutriKane D – was launched on Australia Day in 2018 after two (2) years of test marketing. The hospital product – NutriKane+ is currently being used as a pre/post-treatment in colorectal surgery in the USA.
Both markets for these products are growing strongly, globally.
NutriKane D is currently being launched on Amazon.com and a retail gut health and wellness product has been developed for launch in 2019.
MediKane is currently raising funds to support its growth.
The start point for the products was an observation that plant-based foods often deliver significant health benefits when dosed regularly, and are safe, with virtually no side-effects. This is consistent with the fact that today over 80 % of pharmaceutical drugs are derived from plants.
MediKane decided to approach the products and our market in a similar manner to the development of pharmaceutical products. Specifically, that meant we rely on extensive independent analysis and testing, evaluation of the products and Modes of Action, and finally clinical trials to evidence and demonstrate both the effectiveness and safety of the products.
Finally, MediKane claims and product benefits are based on tests of the final consumer product and do not rely on alleged claims that are associated with the raw materials, as many competing products do.